5 results about "Neisseria" patented technology

The invention belongs to the technical field of biological medicines, and particularly relates to a neisseria gonorrhoeae chromogenic culture medium. According to the chromogenic culture medium, a supplement and a composite bacteriostatic agent are additionally added into a gonococcus culture medium, and the supplement is prepared from 50-200 ml / L of horse serum, 1-20 mg / L of hemin chloride, 25-250 mg / L of L-proline beta-naphthylamide hydrochloride, 500-5000 mg / L of 1, 3, 4-trimethyl-1, 3-pentanediol monoisobutyrate, 10-20 mg / L of sodium chloride, 10-20 mg / L of sodium chloride, 10-20 mg / L of sodium chloride, 10-20 mg / L of sodium chloride and 10-20 mg / L of sodium chloride. The invention relates to a neisseria gonorrhoeae culture medium, which is characterized in that neisseria gonorrhoeae in a sample can be directly separated and identified by adopting the culture medium, and a separated bacterial colony can be directly used for a drug sensitive test. The neisseria gonorrhoeae can be directly separated and identified by adopting the neisseria gonorrhoeae culture medium for the drug sensitive test of neisseria gonorrhoeae in the sample.

Isolated antigen binding polypeptides having a heavy chain variable region and / or light chain variable region that specifically binds to a lipo-oligosaccharide (LOS) epitope of Neisseria gonorrhoeae as well as antibodies and antigen binding antibody fragments containing the heavy chain variable region and / or the light chain variable region that bind to a lipo-oligosaccharide (LOS) epitope of Neisseria gonorrhoeae are provided. Pharmaceutical compositions and kits comprising the isolated antigen binding polypeptide and antibodies or antigen binding antibody fragments thereof comprising the antigen binding polypeptide are also provided, along with methods of treating an infection caused by Neisseria gonorrhoeae and methods of making the polypeptides, antibodies and antigen-binding antibody fragments.